Kenya Neurological Disorders Drug Market Expected to Grow Faster According to New Research Report 2023-2028

The Kenya Neurological Disorders Drug Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Kenya Neurological Disorders Drug market. This report explores all the key factors affecting the growth of the global Kenya Neurological Disorders Drug market, including demand-supply scenario, pricing structure, profit margins, production, and value chain analysis.

Get PDF Sample Report Now! @ https://www.prudentmarkets.com/sample-request/141628/

Report Overview

The Neurological disorders Drug market size in Kenya stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Neurological disorders are a group of disorders affecting the structure and function of the Central Nervous System (Brain and Spinal Cord) of the body mainly in adults. According to the research study conducted in Kenyas leading public health tertiary institutions, Kenyatta National Hospital and Moi Teaching and Referral Hospital in 2018, Overall, ischaemic stroke accounted for 55.6% of the stroke cases, with women being the most affected (57.5%). The most common risk factors were hypertension, smoking, and diabetes. One in four Kenyans aged 1869years have elevated blood pressure. The prevalence of hypertension is higher among women and urban residents than among men and rural residents. Alzheimers and Parkinsons Disease account for the leading causes of mortality due to neurodegenerative diseases. Limited knowledge of prevalence of Parkinsons disease in Kenya has resulted in it being neglected and its symptoms often confused with ageing.

Market Drivers

The market is majorly driven by the rising burden of Non-Communicable Diseases (NCDs) in Kenya. High prevalence of uncontrolled hypertension among Kenyan population and subsequent complications like stroke is creating growth opportunities in the Neurological Drug market. In Kenya, a quarter of the population aged 1869years is estimated to be hypertensive and a half pre-hypertensive.

Surge in lifestyle-associated neurological disorders among young population is expected to fuel growth in the market. Increase in prevalence of smokers, substance abuse, depression among young population and other risk factors will propel growth in the forecasted period.

Development of new and more efficient drugs by leading pharmaceutical companies will drive growth in the neurological Drug market during the forecast period.

However, there is a serious dearth of neurologists in the country that restricts growth of the market. There are only 20 neurologists practicing in Kenya and most of them are concentrated in three major cities of Nairobi, Mombasa and Kisumu. There are no neurologists in rural Kenya.

To Know More About COVID-19 Impact On Kenya Neurological Disorders Drug Market @ https://www.prudentmarkets.com/sample-request/141628/

Market Segmentation

By Disease Type:

On the basis of disease type, the neurological Drug market in Kenya is segmented into Parkinson's disease, Alzheimer's disease, Multiple Sclerosis, Dementia, Migraine, Cerebrovascular diseases, Epilepsy and Psychotic disorders.

Cerebrovascular disease segment including Ischemic stroke and haemorrhagic stroke will grow at the fastest rate in the forecast period due to the high burden of hypertensive population in the country.

By Drug Class:

On the basis of drug class, the neurological Drug market can be segmented into anti- cholinergic, dopaminergic agonist, enzyme inhibitors, anti-epileptics, anti-hypertensives, sedatives, anti-psychotics and other drug classes.

Anti-Hypertensive drug segment will witness the fastest growth and hold the largest share in the market.

By Distribution Channels:

On the basis of distribution channels, the market can be segmented into hospital pharmacies, retail pharmacies, online and others.

Retail pharmacies account for the highest market share based on revenues generated.

Major Players

Large pharmaceutical companies are investing heavily in the development of new drugs and therapies to treat neurological disorders. Some of the major players in the market are Eli Lilly, Novartis AG, Johnson & Johnson services, Pfizer, Inc. and Merck & Co.

Prudent Markets provides attractive discounts that fit your needs. Customization of the reports as per your requirement is also offered. Get in touch with our sales team, who will guarantee you a report that suits your needs.

Speak To Our Analyst For A Discussion On The Above Findings, And Ask For A Discount On The Report @ https://www.prudentmarkets.com/discount-request/141628/

The report covers the competitive analysis of the market. As the demand is driven by a buyer's paying capacity and the rate of item development, the report shows the important regions that will direct growth. This section exclusively shares insight into the budget reports of big-league members of the market helping key players and new entrants understand the potential of investments in the Global Kenya Neurological Disorders Drug Market. It can be better employed by both traditional and new players in the industry for complete know-how of the market.

Strategic Points Covered in Table of Content of Global Kenya Neurological Disorders Drug Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Kenya Neurological Disorders Drug market
Chapter 2: Exclusive Summary - the basic information of the Kenya Neurological Disorders Drug Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the Kenya Neurological Disorders Drug
Chapter 4: Presenting the Kenya Neurological Disorders Drug Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country
Chapter 6: Evaluating the leading manufacturers of the Kenya Neurological Disorders Drug market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Any Questions? Feel Free To Enquire Here. We Will put you on the Right Path @ https://www.prudentmarkets.com/enquiry-request/141628/

Free Customization on the basis of client requirements on Immediate purchase:
1- Free country-level breakdown of any 5 countries of your interest.
2- Competitive breakdown of segment revenue by market players.

Customization of the Report:
This report can be customized to meet the client's requirements. Please connect with our sales team (sales@prudentmarkets.com), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +91 83560 50278 || USA/Canada(Toll Free): 1800-601-6071 to share your research requirements.

Get ready to Recognize the pros and cons of the regulatory framework, local reforms, and its effect on the Industry. Understand how the Leaders in Intelligent Network are keeping themselves one stage forward with our most up-to-date survey analysis.

In conclusion, the Kenya Neurological Disorders Drug Market report is a genuine source for accessing the research data which is projected to exponentially grow your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis and PESTLE analysis is also incorporated in the report.

Contact Us:
Allan Carter
Andheri, Maharashtra, 400102
USA/Canada(Toll Free): 1800-601-6071
Direct Line: +91 83560 50278
Mail: sales@prudentmarkets.com
Web: www.prudentmarkets.com

About Us:
We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy.

This release was published on openPR.